1. Pink Sheet
  2. >>Compliance
  3. >>Marketing & Advertising

Low NSAID Knowledge, Satisfaction In Consumer Pain Medication Survey

 
• By Eileen Francis

While 60% of consumers use an OTC medicine for pain, nearly a third are not satisfied with the results, according to Kelton Global's research on consumer understanding of pain medication. Nearly half of consumers are not familiar with the term NSAIDs or with FDA recommendations on using the products.

A survey suggests drug firms need to better inform consumers about nonsteroidal anti-inflammatory drugs' potential risks and could tap into a sales growth driver in a sizeable group of consumers who are ignoring their pain.

The research by consultancy Kelton Global for pharmaceutical NSAID marketer Iroko Pharmaceuticals LLC found that 61% of US consumers...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Marketing & Advertising

More from Compliance

UK MHRA: Bacteriophage Developers Wanted ‘More Clarity’ On UK Framework

 
• By Eliza Slawther

Julian Beach, interim executive director of healthcare quality and access at the UK drug regulator, the MHRA, tells the Pink Sheet how the agency is responding to increased efforts to develop bacteriophage therapies.

Novo, Lilly Ad Challenges Cause Discontinued Claims For Compounded GLP-1s

 
• By Sue Sutter

Two pharmacies, a medical spa and a telehealth company voluntarily removed efficacy, safety and quality claims for compounded GLP-1 products after innovator companies filed challenges with the National Advertising Division.

EU Emergency Response Authority Needs Bigger Budget To Address Health Threats, Says Industry

 
• By Eliza Slawther

The EU must renew the mandate of its Health Emergency Response Authority to support medicine stockpiles and enable agile manufacturing to combat antimicrobial resistance and chemical, biological, radiological and nuclear threats, says trade organization EUCOPE.